Abstract
Syngeneic BMT was first performed successfully in China in 1964. In 1981, allogeneic BMT was applied in an acute leukemia patient with success. Since then, the number of BMTs has been increasing gradually, especially since the 1990s. More than 2000 stem cell transplants per year have been performed in recent years in more than 50 BMT units in mainland China. A survey of 16 BMT units from 1986 to 2005 indicates that the predominant types of transplantation performed are identical sibling (36%), related mismatched/haploidentical (11.2%), unrelated (7.5%) and autologous (44.5%) and that the distribution of disease entities and prevalent diseases being transplanted are AML (31%), ALL (16.1%), CML (19.1%) and lymphoid malignancy (22.2%). The number of transplants from unrelated donor or related mismatched/haploidentical donor has increased significantly in the past 5 years. BM and G-CSF-mobilized peripheral blood are used about equally often as a source of hematopoietic stem cells, or they are used in combination. Umbilical cord blood is used least often. Leukemias for allogeneic and lymphoid malignancies for autologous BMT continue to increase, but the increase in BMT for CML has been slow since 2004. By the end of 2007, HLA data were available on more than 700 000 individuals in the Chinese Marrow Donor Program, and 800 stem cell donations have been carried out from these. Related HLA-mismatched/haploidentical BMT has achieved comparable outcomes in terms of severe acute GVHD, chronic GVHD, relapse, treatment-related mortality, disease-free survival (DFS) and overall survival (OS) with HLA-identical sibling transplantation in the author's two BMT units. Cord blood co-infusion as the third-party cells could significantly reduce the incidence and severity of acute GVHD, steroid-refractory acute GVHD and extensive chronic GVHD without an increase in leukemia relapse and could improve DFS and OS.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Han W, Lu DP, Huang XJ, Liu KY, Chen H, Xu LP et al. Mismatched hematopoietic stem cell transplantation using GIAC protocol: report of 100 cases. Chin J Hematol 2004; 25: 453–457.
Lu DP, Dong LJ, Wu T, Huang XJ, Zhang MJ, Han W et al. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood 2006; 107: 3065–3073.
Wu T, Lu DP . Haploidentical blood and marrow transplantation in hematological malignancies: a single-center report of 206 patients. 11th Congress of the International Society of Hematology, Asian-Pacific Division and 12th Congress of the Asian-Pacific Bone Marrow Transplantation, Beijing, 2007.
Lu DP, Gao ZY, Wu T . The role of third party cells in clinical blood and marrow transplantation. 11th Congress of the International Society of Hematology, Asian-Pacific Division and 12th Congress of the Asian-Pacific Bone Marrow Transplantation, Beijing, 2007.
Liu KY . Cord blood transplantation in China. The Fourth Annual Meeting of Asian Hematology Association, Thailand, 2007.
Liu KY, Lu DP . Unrelated cord blood transplantation and banking in Beijing cord blood bank. The Proceedings of the 10th Congress of Asian-Pacific Bone Marrow Transplantation, 2005.
Lu DP, Liu KY, Li D . The Fourth International Symposium of Hematopoietic Stem Cell Transplantation—Future of Cord Blood Stem Cell Transplantation, Tokyo, 2000.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wu, T., Lu, DP. Blood and marrow transplantation in the People's Republic of China. Bone Marrow Transplant 42 (Suppl 1), S73–S75 (2008). https://doi.org/10.1038/bmt.2008.123
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2008.123
Keywords
This article is cited by
-
Hematopoietic SCT activity in Asia: a report from the Asia-Pacific Blood and Marrow Transplantation Group
Bone Marrow Transplantation (2010)